Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masateru Miyake

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 3, 2013
[Improvement and prediction of intestinal drug absorption]Masateru Miyake
Journal of Pharmaceutical Sciences|November 4, 2018
Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber SystemSatoshi Kondo, Masateru Miyake
Journal of Pharmacological Sciences|September 2, 2022
The change of the electrophysiological parameters using human intestinal tissues from ulcerative colitis and Crohn's diseaseDaisuke Nakai, Masateru Miyake
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 25, 2016
Effect of proinflammatory cytokine IL-6 on efflux transport of rebamipide in Caco-2 cellsMasateru Miyake, Daisuke Nakai
Pharmaceutics|January 23, 2024
Intestinal Membrane Function in Inflammatory Bowel DiseaseDaisuke Nakai, Masateru Miyake
Pharmaceutics|December 23, 2023
Simultaneous Prediction Method for Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber SystemSatoshi Kondo, Masateru Miyake
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 3, 2019
Food effect on meal administration time of pharmacokinetic profile of cilostazol, a BCS class II drugMasateru Miyake, Yoshikazu Oka, Tadashi Mukai
Journal of Pharmaceutical Sciences|December 25, 2019
Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues With Ulcerative ColitisDaisuke Nakai, Masateru Miyake, Ayako Hashimoto
Biological & Pharmaceutical Bulletin|September 5, 2017
Inhibitory Potency of Marketed Drugs for Ulcerative Colitis and Crohn's Disease on PEPT1Masateru Miyake, Miki Fujishima, Daisuke Nakai
Biological & Pharmaceutical Bulletin|June 16, 2024
Neuroprotective Effects of Probucol against Rotenone-Induced Toxicity via Suppression of Reactive Oxygen Species Production in SH-SY5Y CellsTsugumi Takeo, Masateru Miyake, Hideya Mizuno
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 3, 2013
[Improvement and prediction of intestinal drug absorption]Masateru Miyake
Journal of Pharmaceutical Sciences|November 4, 2018
Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber SystemSatoshi Kondo, Masateru Miyake
Journal of Pharmacological Sciences|September 2, 2022
The change of the electrophysiological parameters using human intestinal tissues from ulcerative colitis and Crohn's diseaseDaisuke Nakai, Masateru Miyake
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 25, 2016
Effect of proinflammatory cytokine IL-6 on efflux transport of rebamipide in Caco-2 cellsMasateru Miyake, Daisuke Nakai
Pharmaceutics|January 23, 2024
Intestinal Membrane Function in Inflammatory Bowel DiseaseDaisuke Nakai, Masateru Miyake
Pharmaceutics|December 23, 2023
Simultaneous Prediction Method for Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber SystemSatoshi Kondo, Masateru Miyake
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 3, 2019
Food effect on meal administration time of pharmacokinetic profile of cilostazol, a BCS class II drugMasateru Miyake, Yoshikazu Oka, Tadashi Mukai
Journal of Pharmaceutical Sciences|December 25, 2019
Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues With Ulcerative ColitisDaisuke Nakai, Masateru Miyake, Ayako Hashimoto
Biological & Pharmaceutical Bulletin|September 5, 2017
Inhibitory Potency of Marketed Drugs for Ulcerative Colitis and Crohn's Disease on PEPT1Masateru Miyake, Miki Fujishima, Daisuke Nakai
Biological & Pharmaceutical Bulletin|June 16, 2024
Neuroprotective Effects of Probucol against Rotenone-Induced Toxicity via Suppression of Reactive Oxygen Species Production in SH-SY5Y CellsTsugumi Takeo, Masateru Miyake, Hideya Mizuno
Pageof 4